These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37491379)

  • 1. Downregulation of miR-182-5p by NFIB promotes NAD+ salvage synthesis in colorectal cancer by targeting NAMPT.
    Zhou L; Liu H; Chen Z; Chen S; Lu J; Liu C; Liao S; He S; Chen S; Zhou Z
    Commun Biol; 2023 Jul; 6(1):775. PubMed ID: 37491379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.
    Sun L; Fang Y; Wang X; Han Y; Du F; Li C; Hu H; Liu H; Liu Q; Wang J; Liang J; Chen P; Yang H; Nie Y; Wu K; Fan D; Coffey RJ; Lu Y; Zhao X; Wang X
    Theranostics; 2019; 9(26):8409-8425. PubMed ID: 31754405
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting the NAD
    Ye C; Qi L; Li X; Wang J; Yu J; Zhou B; Guo C; Chen J; Zheng S
    Cell Commun Signal; 2020 Jan; 18(1):16. PubMed ID: 32005247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance.
    Liu Z; Chen J; Yuan W; Ruan H; Shu Y; Ji J; Wu L; Tang Q; Zhou Z; Zhang X; Cheng Y; He S; Shu X
    Cancer Sci; 2019 Jan; 110(1):86-98. PubMed ID: 30320939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-365 promotes cutaneous squamous cell carcinoma (CSCC) through targeting nuclear factor I/B (NFIB).
    Zhou M; Zhou L; Zheng L; Guo L; Wang Y; Liu H; Ou C; Ding Z
    PLoS One; 2014; 9(6):e100620. PubMed ID: 24949940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
    Gao Y; Huang Y
    J Chemother; 2023 Apr; 35(2):117-130. PubMed ID: 35380509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p.
    Zhao Y; Ma X; Shi W
    Mamm Genome; 2021 Dec; 32(6):517-529. PubMed ID: 34632534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effect of LncRNA DRAIC/miR-149-5p/NFIB molecular network on autophagy of esophageal cancer cells and its biological behavior.
    Li F; Zhou X; Chen M; Fan W
    Exp Mol Pathol; 2020 Oct; 116():104491. PubMed ID: 32659236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ_0082182 upregulates the NFIB level via sponging miR-326 to promote oxaliplatin resistance and malignant progression of colorectal cancer cells.
    Wang Z; Liu J; Yang T; Wang Q; Liang R; Tang J
    Mol Cell Biochem; 2023 May; 478(5):1045-1057. PubMed ID: 36219357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer.
    Ju HQ; Zhuang ZN; Li H; Tian T; Lu YX; Fan XQ; Zhou HJ; Mo HY; Sheng H; Chiao PJ; Xu RH
    Cancer Lett; 2016 Aug; 379(1):1-11. PubMed ID: 27233476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p.
    Chen H; Yu C; Shen L; Wu Y; Wu D; Wang Z; Song G; Chen L; Hong Y
    Pathol Res Pract; 2020 Dec; 216(12):153236. PubMed ID: 33038688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevoflurane inhibits the malignant phenotypes of glioma through regulating miR-146b-5p/NFIB axis.
    Wang H; Cheng G; Quan L; Qu H; Yang A; Ye J; Feng Y; Li X; Shi X; Pan H
    Metab Brain Dis; 2022 Jun; 37(5):1373-1386. PubMed ID: 35386035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-626 promotes the malignant behavior of oral cancer cells by targeting NFIB.
    Lou C; Shi J; Xu Q
    Mol Biol Rep; 2022 Jun; 49(6):4829-4840. PubMed ID: 35711020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.
    Liu QY; Jiang XX; Tian HN; Guo HL; Guo H; Guo Y
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7266-7275. PubMed ID: 32706064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA LINC00461 Promotes Colorectal Cancer Progression via miRNA-323b-3p/NFIB Axis.
    Yu H; Ma J; Chen J; Yang Y; Liang J; Liang Y
    Onco Targets Ther; 2019; 12():11119-11129. PubMed ID: 31908480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA small nucleolar RNA host gene 12/microRNA-138-5p/nuclear factor I/B regulates neuronal apoptosis, inflammatory response, and oxidative stress in Parkinson's disease.
    Yan L; Li L; Lei J
    Bioengineered; 2021 Dec; 12(2):12867-12879. PubMed ID: 34783303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD.
    Alizadeh-Fanalou S; Hosseinkhani S; Nazarizadeh A; Ezzati-Mobaser S; Hesari Z; Aziminezhadan P; Abdolvahabi Z; Abolmaali M; Tavakoli-Yaraki M; Nourbakhsh M
    DNA Cell Biol; 2021 Jul; 40(7):1026-1036. PubMed ID: 34101492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB.
    Lin D; Wang Y; Lei L; Lin C
    Autoimmunity; 2022 Mar; 55(2):127-135. PubMed ID: 35001739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p/NFIB axis in diffuse large B-cell lymphoma.
    Tian M; Li Y; Zheng W; Liu QQ; Zhang XL; Liu JL; Zhang S; Sheng YX; Fan CB; Zhang WL
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2567-2576. PubMed ID: 33829443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-335-5p Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer through Downregulating LDHB.
    Zhang D; Yang N
    J BUON; 2019; 24(3):1128-1136. PubMed ID: 31424671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.